Cronos Group (TSE:CRON) Stock Price Down 0.3% – What’s Next?

Shares of Cronos Group Inc. (TSE:CRON) were down 0.3% during mid-day trading on Thursday . The stock traded as low as C$3.47 and last traded at C$3.49. Approximately 97,764 shares traded hands during trading, a decline of 46% from the average daily volume of 179,909 shares. The stock had previously closed at C$3.50.

Cronos Group Price Performance

The stock has a market capitalization of C$1.34 billion, a price-to-earnings ratio of 31.73, a P/E/G ratio of 0.12 and a beta of 1.20. The company’s 50-day simple moving average is C$3.52 and its 200-day simple moving average is C$3.21. The company has a debt-to-equity ratio of 0.17, a current ratio of 24.24 and a quick ratio of 24.01.

Cronos Group (TSE:CRON) last released its quarterly earnings results on Thursday, November 6th. The company reported C$0.07 earnings per share (EPS) for the quarter. The business had revenue of C$50.60 million during the quarter. Cronos Group had a negative return on equity of 4.40% and a negative net margin of 42.65%. Research analysts forecast that Cronos Group Inc. will post -0.26 earnings per share for the current fiscal year.

Cronos Group Company Profile

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth.